These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37924689)

  • 21. Efficacy of Shu-yi-ning-chang decoction on IBS-D: Modulating Nr4a3 pathway to reduce visceral hypersensitivity.
    Guo Y; Lu Q; Yang XJ; He Y; Wu Y; Qin B; Li T; Duan M; Liu N; Wu X; He Y
    PLoS One; 2024; 19(4):e0299376. PubMed ID: 38630738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Tongxie-Yaofang Regulates Intestinal Synaptic Plasticity by Activating Enteric Glial Cells and NGF/TrkA Pathway in Diarrhea-Predominant Irritable Bowel Syndrome Rats.
    Lu X; Zhang S
    Drug Des Devel Ther; 2023; 17():2969-2983. PubMed ID: 37789966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect and Mechanism of Sancao Lichang Decoction on Diarrhea- Predominant Irritable Bowel Syndrome by Regulating Tlr4/Myd88/Nf-Κb Pathway.
    Zhang P; Ma Y; Wang Z; Tang D
    Comb Chem High Throughput Screen; 2023; 26(13):2372-2379. PubMed ID: 36856180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome.
    Chen Q; Zhang H; Sun CY; He QY; Zhang RR; Luo BF; Zhou ZH; Chen XF
    Mol Med; 2023 Jan; 29(1):5. PubMed ID: 36635623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sishen Wan enhances intestinal barrier function via regulating endoplasmic reticulum stress to improve mice with diarrheal irritable bowel syndrome.
    Zhao Y; Zhan J; Sun C; Zhu S; Zhai Y; Dai Y; Wang X; Gao X
    Phytomedicine; 2024 Jul; 129():155541. PubMed ID: 38579640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZO-1 and IL-1RAP Phosphorylation: Potential Role in Mediated Brain-Gut Axis Dysregulation in Irritable Bowel Syndrome-like Stressed Mice.
    He YQ; Zhu JR; Sun WJ; Luo YY; Wu XF; Yang M; Chen DF
    Int J Med Sci; 2024; 21(9):1738-1755. PubMed ID: 39006851
    [No Abstract]   [Full Text] [Related]  

  • 27. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multi-omics study reveals the therapeutic effect of Linderae Radix water extract on irritable bowel syndrome (IBS-D).
    Ouyang L; Liu T; He Y; He Y; Xu W; Deng G; Deng G; Xiao X
    J Ethnopharmacol; 2024 Jun; 328():118050. PubMed ID: 38518966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of moxibustion on immune function homeostasis in rats with diarrhea irritable bowel syndrome based on SCF/c-kit signaling pathway].
    Li KW; Chu HR; Ruan JR; Wang JJ; Chen JY; Zhu SS; Zou L; Liao LM; Tong TT
    Zhongguo Zhen Jiu; 2023 Feb; 43(2):177-85. PubMed ID: 36808512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Puerarin from
    Wang QS; Wang YL; Zhang WY; Li KD; Luo XF; Cui YL
    Food Funct; 2021 Mar; 12(5):2211-2224. PubMed ID: 33595580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of moxibustion of "biaoben acupoint combination" on heart rate variability, atrial natriuretic peptide in the model rats of IBS-D complicated with anxiety].
    Wu F; Li J; Wang JZ; Wang H; Wu S; Lu W
    Zhongguo Zhen Jiu; 2023 Oct; 43(10):1139-47. PubMed ID: 37802520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The relationship between adherens junction and tight junction and clinical symptoms in patients with diarrhea predominant irritable bowel syndrome].
    Zhang M; Chen CY; Hu Y; Lyu B
    Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):40-46. PubMed ID: 31887835
    [No Abstract]   [Full Text] [Related]  

  • 33. Berberine Enhances Intestinal Mucosal Barrier Function by Promoting Vitamin D Receptor Activity.
    Huang YQ; Liu JL; Chen GX; Shen DT; Zhu W; Chen XL; Liu FB; Hou QK
    Chin J Integr Med; 2024 Feb; 30(2):143-151. PubMed ID: 37046128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringin.
    Cai T; Wang X; Li B; Xiong F; Wu H; Yang X
    Phytomedicine; 2021 Jun; 86():153527. PubMed ID: 33845366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ameliorating effects of electroacupuncture on the low-grade intestinal inflammation in rat model of diarrhea-predominant irritable bowel syndrome.
    Li X; Ren K; Hong X; Guo S; Yu S; Yang S
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1963-1974. PubMed ID: 35959628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electroacupuncture protects the intestinal mucosal barrier in diarrhea-predominant Irritable Bowel Syndrome rats by regulating the MCs/Tryptase/PAR-2/MLCK pathway.
    Han XY; Song XG; Ma WL; Fang M; Zhu JW; Ruan JR; Li KW; Zou L; Liao LM; Li XM; Wang ZY; Fang YC; Chu HR
    Am J Transl Res; 2024; 16(3):781-793. PubMed ID: 38586088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
    Singh P; Silvester J; Chen X; Xu H; Sawhney V; Rangan V; Iturrino J; Nee J; Duerksen DR; Lembo A
    United European Gastroenterol J; 2019 Jun; 7(5):709-715. PubMed ID: 31210949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
    Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome.
    Sun J; Zhang M; Liu W; Liu Y; Zhang D; Fan X; Zhang J; Li T; Lu M
    Front Microbiol; 2023; 14():1160783. PubMed ID: 37440881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR; Xu XJ; Yao SK
    World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.